GOHEALTH INC-CLASS A (GOCO) Stock Fundamental Analysis

NASDAQ:GOCO • US38046W2044

1.61 USD
-0.04 (-2.42%)
Last: Feb 19, 2026, 03:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GOCO. GOCO was compared to 149 industry peers in the Insurance industry. Both the profitability and financial health of GOCO have multiple concerns. GOCO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year GOCO has reported negative net income.
  • GOCO had a negative operating cash flow in the past year.
  • In the past 5 years GOCO always reported negative net income.
  • In multiple years GOCO reported negative operating cash flow during the last 5 years.
GOCO Yearly Net Income VS EBIT VS OCF VS FCFGOCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • The Return On Assets of GOCO (-19.69%) is worse than 93.96% of its industry peers.
  • With a Return On Equity value of -163.55%, GOCO is not doing good in the industry: 92.62% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.69%
ROE -163.55%
ROIC N/A
ROA(3y)-4.54%
ROA(5y)-4.73%
ROE(3y)-23.85%
ROE(5y)-26.03%
ROIC(3y)N/A
ROIC(5y)N/A
GOCO Yearly ROA, ROE, ROICGOCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • With an excellent Gross Margin value of 80.50%, GOCO belongs to the best of the industry, outperforming 97.99% of the companies in the same industry.
  • GOCO's Gross Margin has improved in the last couple of years.
  • GOCO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y4.06%
GOCO Yearly Profit, Operating, Gross MarginsGOCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • GOCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GOCO has been increased compared to 1 year ago.
  • The number of shares outstanding for GOCO has been increased compared to 5 years ago.
  • Compared to 1 year ago, GOCO has an improved debt to assets ratio.
GOCO Yearly Shares OutstandingGOCO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
GOCO Yearly Total Debt VS Total AssetsGOCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • GOCO has an Altman-Z score of -0.13. This is a bad value and indicates that GOCO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.13, GOCO is in the better half of the industry, outperforming 67.79% of the companies in the same industry.
  • GOCO has a Debt/Equity ratio of 4.69. This is a high value indicating a heavy dependency on external financing.
  • GOCO has a worse Debt to Equity ratio (4.69) than 93.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.69
Debt/FCF N/A
Altman-Z -0.13
ROIC/WACCN/A
WACC10.96%
GOCO Yearly LT Debt VS Equity VS FCFGOCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.64 indicates that GOCO should not have too much problems paying its short term obligations.
  • GOCO has a better Current ratio (1.64) than 88.59% of its industry peers.
  • A Quick Ratio of 1.64 indicates that GOCO should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.64, GOCO belongs to the top of the industry, outperforming 88.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
GOCO Yearly Current Assets VS Current LiabilitesGOCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for GOCO have decreased strongly by -192.86% in the last year.
  • The Revenue has been growing slightly by 7.56% in the past year.
  • GOCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.17% yearly.
EPS 1Y (TTM)-192.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2665.22%
Revenue 1Y (TTM)7.56%
Revenue growth 3Y-9.06%
Revenue growth 5Y8.17%
Sales Q2Q%-71.1%

3.2 Future

  • The Earnings Per Share is expected to decrease by -47.03% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -5.41% on average over the next years.
EPS Next Y-1669.19%
EPS Next 2Y-120.17%
EPS Next 3Y-47.03%
EPS Next 5YN/A
Revenue Next Year-40.2%
Revenue Next 2Y-33.27%
Revenue Next 3Y-5.41%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GOCO Yearly Revenue VS EstimatesGOCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
GOCO Yearly EPS VS EstimatesGOCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GOCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GOCO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GOCO Price Earnings VS Forward Price EarningsGOCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GOCO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.98
GOCO Per share dataGOCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as GOCO's earnings are expected to decrease with -47.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-120.17%
EPS Next 3Y-47.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GOCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GOHEALTH INC-CLASS A

NASDAQ:GOCO (2/19/2026, 3:15:42 PM)

1.61

-0.04 (-2.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-13
Earnings (Next)03-12
Inst Owners34.46%
Inst Owner Change8.31%
Ins Owners10.42%
Ins Owner Change-0.14%
Market Cap46.22M
Revenue(TTM)738.34M
Net Income(TTM)-202.88M
Analysts78
Price Target11.12 (590.68%)
Short Float %5.07%
Short Ratio9.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-188.35%
Min EPS beat(2)-472.14%
Max EPS beat(2)95.44%
EPS beat(4)2
Avg EPS beat(4)-91.38%
Min EPS beat(4)-472.14%
Max EPS beat(4)95.44%
EPS beat(8)3
Avg EPS beat(8)-46.66%
EPS beat(12)5
Avg EPS beat(12)-78.63%
EPS beat(16)8
Avg EPS beat(16)19.49%
Revenue beat(2)0
Avg Revenue beat(2)-43.47%
Min Revenue beat(2)-67.47%
Max Revenue beat(2)-19.48%
Revenue beat(4)1
Avg Revenue beat(4)-17.75%
Min Revenue beat(4)-67.47%
Max Revenue beat(4)17.54%
Revenue beat(8)3
Avg Revenue beat(8)-14.1%
Revenue beat(12)4
Avg Revenue beat(12)-15.23%
Revenue beat(16)6
Avg Revenue beat(16)-7.98%
PT rev (1m)0%
PT rev (3m)-42.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-159.2%
EPS NY rev (1m)-1.09%
EPS NY rev (3m)-315.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-76.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-45.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA 8.98
EPS(TTM)-10.25
EYN/A
EPS(NY)-5.28
Fwd EYN/A
FCF(TTM)-2.74
FCFYN/A
OCF(TTM)-2.38
OCFYN/A
SpS25.72
BVpS4.32
TBVpS4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.69%
ROE -163.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.5%
FCFM N/A
ROA(3y)-4.54%
ROA(5y)-4.73%
ROE(3y)-23.85%
ROE(5y)-26.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y4.06%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 4.69
Debt/FCF N/A
Debt/EBITDA 8.75
Cap/Depr 9.82%
Cap/Sales 1.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z -0.13
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)12.86%
Cap/Depr(5y)14.35%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-192.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2665.22%
EPS Next Y-1669.19%
EPS Next 2Y-120.17%
EPS Next 3Y-47.03%
EPS Next 5YN/A
Revenue 1Y (TTM)7.56%
Revenue growth 3Y-9.06%
Revenue growth 5Y8.17%
Sales Q2Q%-71.1%
Revenue Next Year-40.2%
Revenue Next 2Y-33.27%
Revenue Next 3Y-5.41%
Revenue Next 5YN/A
EBIT growth 1Y35.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.43%
EBIT Next 3Y53.01%
EBIT Next 5YN/A
FCF growth 1Y-519.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2033.41%
OCF growth 3YN/A
OCF growth 5YN/A

GOHEALTH INC-CLASS A / GOCO FAQ

What is the ChartMill fundamental rating of GOHEALTH INC-CLASS A (GOCO) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GOCO.


Can you provide the valuation status for GOHEALTH INC-CLASS A?

ChartMill assigns a valuation rating of 0 / 10 to GOHEALTH INC-CLASS A (GOCO). This can be considered as Overvalued.


What is the profitability of GOCO stock?

GOHEALTH INC-CLASS A (GOCO) has a profitability rating of 2 / 10.


How financially healthy is GOHEALTH INC-CLASS A?

The financial health rating of GOHEALTH INC-CLASS A (GOCO) is 3 / 10.